Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation

Autor: Blyth, Emily *, Clancy, Leighton, Simms, Renee, Ma, Chun K.K., Burgess, Jane, Deo, Shivashni, Byth, Karen, Dubosq, Ming-Celine, Shaw, Peter J., Micklethwaite, Kenneth P., Gottlieb, David J.
Zdroj: In Blood 2 May 2013 121(18):3745-3758
Databáze: ScienceDirect